Section Arrow
AVR.NASDAQ
- Anteris Technologies Global Corp
Quotes are at least 15-min delayed:2026/11/20 17:25 EST
After Hours
Last
 5.09
+0.1 (+2.00%)
Bid
4.99
Ask
5.2
High 5.09 
Low 4.99 
Volume 23.25K 
Regular Hours (Closed)
Last
 4.99
-0.1 (-1.96%)
Day High 
5.18 
Prev. Close
5.09 
1-M High
6.585 
Volume 
1.54M 
Bid
4.99
Ask
5.2
Day Low
4.92 
Open
5.05 
1-M Low
4.89 
Market Cap 
496.24M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.63 
20-SMA 5.79 
50-SMA 6.7 
52-W High 11.055 
52-W Low 3.53 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.60/--
Enterprise Value
497.94M
Balance Sheet
Book Value Per Share
2.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.73M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 41.9407 -0.0393 -0.09%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.61 -0.02 -1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.5 -0.44 -0.44%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.9699 +0.0609 +6.70%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 104.43 +1.43 +1.39%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THVis a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.